| 41.30 | -0.51 / -1.22% |
Data as of 4:01pm ET | Day’s Change |
| 41.30 | |
Volume: 4.1K |
| Interesting HAE Put For July May 20 / TheStreet.com | HAE Crosses Above Key Moving Average Level May 16 / TheStreet.com |
| Previous close | 41.81 |
| Today’s open | 41.82 |
| Day’s range | 41.21 - 42.48 |
| Volume | 497,562 |
| Average volume (3 months) | 298,918 |
| Market cap | $2.1B |
| Dividend yield | -- |
| Earnings growth (last year) | -42.86% |
| Earnings growth (this year) | +36.37% |
| Earnings growth (next 5 years) | +13.00% |
| Revenue growth (last year) | +22.55% |
| P/E ratio | 55.8 |
| Price/Sales | 2.40 |
| Price/Book | -- |
| Today’s change | Today’s % change | |
|---|---|---|
| WSTWest Pharmaceutical ... | -1.07 | -1.56% |
| PODDInsulet Corp | -1.05 | -3.53% |
| DXCMDexCom Inc | -0.77 | -3.64% |
| GMEDGlobus Medical Inc | -0.53 | -3.35% |
| Next reporting date | August 5, 2013 |
| EPS forecast (this quarter) | $0.45 |
| Annual revenue (last year) | $892.0M |
| Annual profit (last year) | $38.8M |
| Net profit margin | 4.35% |
Sector Health Technology |
Industry Medical Specialties |
President, Chief Executive Officer & Director Brian P. Concannon |
Chief Financial Officer & VP-Business Development Christopher J. Lindop, CPA |
Corporate headquarters Braintree, Massachusetts |
